• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Meiwu Technology Co., Ltd. Announces MOU with Real BioTech (Qingdao) Ltd.

    12/3/25 5:00:00 PM ET
    $WNW
    Catalog/Specialty Distribution
    Consumer Discretionary
    Get the next $WNW alert in real time by email

    Xiamen, China, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Meiwu Technology Co., Ltd. (hereinafter referred to as " Meiwu" or the "Company") (NASDAQ:WNW), a leading integrated platform in the beauty industry, announced that the Company signed a non-binding Strategic Cooperation Memorandum of Understanding ("MOU") on November 25, 2025, with Real BioTech (Qingdao) Ltd. ("Real Biotech"), a marine biotechnology enterprise based in Qingdao, China. The MOU aims to establish a strategic partnership between the two parties, jointly dedicated to expanding the Company's market shares in the beauty market in China and globally.​

    Pursuant to the terms of the MOU, both parties will integrate their core strengths and resources to drive synergistic growth:​

    • Meiwu operates as a platform integrating R&D, packaging, promotion, sales of functional skincare products, and talent training for retail stores.​
    • Real Biotech specializes in marine biotechnology development and promotion; R&D, production, and sales of food, medical devices, cosmetics, marine biological hemostatic materials, and wound dressings; as well as the cultivation, processing, and sales of marine microalgae.​

    Through this strategic cooperation, Real Biotech plans to leverage its R&D capabilities and marine biological resources to provide Meiwu with R&D support, technical services, and technical consulting. Meiwu believes this collaboration will enhance its capabilities in the beauty sector, particularly in the development of beauty solutions utilizing marine active ingredients, which the Company believes is a high-growth segment in the global beauty market driven by increasing consumer demand for natural, science-backed skincare products.​

    The Company believes that this partnership aligns with Meiwu's long-term strategy. By combining Real Biotech's expertise in marine biotechnology with Meiwu's brand operation and distribution network, the Company believes that the two parties are positioned to capture new opportunities in the rapidly evolving beauty industry, delivering enhanced value to customers, shareholders, and partners alike.​

    About Meiwu Technology Co., Ltd. (NASDAQ:WNW)​

    Meiwu Technology Co., Ltd. is committed to providing high-quality functional skincare products and professional services through its subsidiaries in China. For more information, please visit the Company's official website: www.wnw108.com.​



    Forward-Looking Statements​

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements regarding the expected benefits of the strategic cooperation, the expansion of the efficacious beauty market, and the Company's future business development. These statements are based on current expectations, estimates, and projections of the Company's management, and involve certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements. Factors that may affect actual results include, but are not limited to, changes in market conditions, regulatory developments, the ability to successfully implement the cooperation plan, and other risks and uncertainties described in the Company's filings with the U.S. Securities and Exchange Commission (SEC). The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

    Contact

    Meiwu Technology Company Limited

    Zhichao Yang

    Email: [email protected]



    Primary Logo

    Get the next $WNW alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $WNW

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $WNW
    SEC Filings

    View All

    Amendment: SEC Form F-1/A filed by Meiwu Technology Company Limited

    F-1/A - Meiwu Technology Co Ltd (0001787803) (Filer)

    11/19/25 5:25:30 PM ET
    $WNW
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form F-1 filed by Meiwu Technology Company Limited

    F-1 - Meiwu Technology Co Ltd (0001787803) (Filer)

    11/18/25 4:16:04 PM ET
    $WNW
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form 6-K filed by Meiwu Technology Company Limited

    6-K - Meiwu Technology Co Ltd (0001787803) (Filer)

    11/5/25 4:16:52 PM ET
    $WNW
    Catalog/Specialty Distribution
    Consumer Discretionary

    $WNW
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Meiwu Technology Co., Ltd. Announces MOU with Real BioTech (Qingdao) Ltd.

    Xiamen, China, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Meiwu Technology Co., Ltd. (hereinafter referred to as " Meiwu" or the "Company") (NASDAQ:WNW), a leading integrated platform in the beauty industry, announced that the Company signed a non-binding Strategic Cooperation Memorandum of Understanding ("MOU") on November 25, 2025, with Real BioTech (Qingdao) Ltd. ("Real Biotech"), a marine biotechnology enterprise based in Qingdao, China. The MOU aims to establish a strategic partnership between the two parties, jointly dedicated to expanding the Company's market shares in the beauty market in China and globally.​ Pursuant to the terms of the MOU, both parties will integrate their core strength

    12/3/25 5:00:00 PM ET
    $WNW
    Catalog/Specialty Distribution
    Consumer Discretionary

    Meiwu Technology Company Limited and Shenzhen Zhinuo Weichuang Technology Co., Ltd Form Strategic Partnership

    SHENZHEN, China, July 02, 2025 (GLOBE NEWSWIRE) -- Meiwu Technology Company Limited ("WNW" or the "Company"), (NASDAQ:WNW) announced today that today that it entered into an agreement with Shenzhen Zhinuo Weichuang Technology Co., Ltd. ("Zhinuo Weichuang") to enhance the Company's brand influence and market competitiveness. Zhinuo Weichuang, based in Guangdong China, primarily engages in the research, development, and sale of technology products in the fields of smart technology, AI-driven finance, and the internet, as well as the provision of intelligent services and investment-related activities. The Company engaged Zhinuo Weichuang for its comprehensive marketing services for a term fr

    7/1/25 4:15:00 PM ET
    $WNW
    Catalog/Specialty Distribution
    Consumer Discretionary

    Meiwu Technology Company Limited and Shenzhen Zhinuoweichuang Technology Co., Ltd Form Strategic Partnership

    Shenzhen, China, June 17, 2025 (GLOBE NEWSWIRE) -- Meiwu Technology Company Limited ("WNW" or the "Company"), (NASDAQ:WNW) announced today that today that it entered into an agreement with Shenzhen Zhinuo Weichuang Technology Co., Ltd.("Zhinuo Weichuang") to enhance the Company's brand influence and market competitiveness. Zhinuo Weichuang, based in Guangdong China, primarily engages in the research, development, and sale of technology products in the fields of smart technology, AI-driven finance, and the internet, as well as the provision of intelligent services and investment-related activities. The Company engaged Zhinuo Weichuang for its comprehensive marketing services for a term fro

    6/17/25 8:30:00 AM ET
    $WNW
    Catalog/Specialty Distribution
    Consumer Discretionary

    $WNW
    Financials

    Live finance-specific insights

    View All

    Meiwu Technology Company Limited Received Nasdaq Notification Letter Regarding Bid Price Deficiency

    Shenzhen, China, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Meiwu Technology Company Limited ("WNW" or the "Company"), (NASDAQ:WNW) announced today that on September 10, 2024, the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC ("Nasdaq") notifying the Company that the minimum bid price per share for its ordinary shares has been below $1.00 for a period of 30 consecutive business days and the Company therefore no longer meets the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2). The notification received has no immediate effect on the listing of the Company's ordinary shares on Nasdaq. Under the Nasdaq Li

    9/11/24 4:15:00 PM ET
    $WNW
    Catalog/Specialty Distribution
    Consumer Discretionary

    Meiwu Technology Co., Limited Received Nasdaq Notification Letter Related to Late Filing of Annual Report on Form 20-F

    Shenzhen, China, June 05, 2024 (GLOBE NEWSWIRE) -- Meiwu Technology Co., Limited (NASDAQ:WNW) ("Meiwu" or the "Company"), an online and mobile commerce company providing organic and green food products to customers on its online platform and in its stores, enterprise short message service ("SMS") and information technology to serve designated medical insurance institutions in China, announced today that it has received a letter from the Nasdaq Stock Market, dated May 31, 2024 (the "Deficiency Letter"), notifying the Company that it is not in compliance with the requirements for continued listing set forth in Nasdaq Listing Rule 5250(c)(1) because it did not timely file its annual report on

    6/5/24 9:00:00 AM ET
    $WNW
    Catalog/Specialty Distribution
    Consumer Discretionary

    Meiwu Technology Co., Limited Regains Compliance with Nasdaq Listing Requirements

    Shenzhen, China, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Meiwu Technology Co., Limited (NASDAQ:WNW) ("Meiwu" or the "Company"), an online and mobile commerce company providing organic and green food products to customers on its online platform and in its stores, enterprise short message service ("SMS") and information technology to serve designated medical insurance institutions in China. The Company today announced on January 9, 2024, it received notice from the NASDAQ Office of General Counsel that the bid price deficiency of Meiwu's ordinary shares has been cured, and Meiwu has regained compliance with NASDAQ Marketplace Rule 5550(a)(2). As a result, a previously scheduled hearin

    1/18/24 8:30:00 AM ET
    $WNW
    Catalog/Specialty Distribution
    Consumer Discretionary

    $WNW
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Meiwu Technology Company Limited

    SC 13G - Meiwu Technology Co Ltd (0001787803) (Subject)

    10/31/23 4:24:23 PM ET
    $WNW
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form SC 13G filed by Meiwu Technology Company Limited

    SC 13G - Meiwu Technology Co Ltd (0001787803) (Subject)

    10/31/23 4:22:35 PM ET
    $WNW
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form SC 13G filed by Meiwu Technology Company Limited

    SC 13G - Meiwu Technology Co Ltd (0001787803) (Subject)

    10/31/23 4:19:58 PM ET
    $WNW
    Catalog/Specialty Distribution
    Consumer Discretionary